ST
A biotechnology company developing gene therapy treatments for rare, debilitating genetic diseases.
About
Spark Therapeutics is a fully integrated, commercial gene therapy company that discovers, develops, and delivers genetic medicines. They focus on treating rare genetic diseases, including inherited retinal diseases, hemophilia, and neurodegenerative disorders, by reawakening healthy biologic processes through one-time gene therapy administration.
Tags
Performance
Company Timeline
No timeline data for this period
Score Breakdown
55Traction
40Team
70Visibility
0Profile
0Community
15Discussion (0)
Join the discussion
No comments yet. Be the first to share your thoughts!
Frequently Asked Questions
What does Spark Therapeutics do?
Spark Therapeutics is a fully integrated, commercial gene therapy company that discovers, develops, and delivers genetic medicines. They focus on treating rare genetic diseases, including inherited retinal diseases, hemophilia, and neurodegenerative disorders, by reawakening healthy biologic processes through one-time gene therapy administration.
How much funding has Spark Therapeutics raised?
Spark Therapeutics has raised a total of $83M in funding. The most recent round on record is Series B.
Where is Spark Therapeutics headquartered?
Spark Therapeutics is headquartered in Philadelphia, United States.
When was Spark Therapeutics founded?
Spark Therapeutics was founded in 2013.
What industry does Spark Therapeutics operate in?
Spark Therapeutics operates in Biotechnology, Gene Therapy, Healthcare, Pharmaceuticals.
What is Spark Therapeutics's current status?
Spark Therapeutics's current operating status is: Acquired.
Similar Startups